Formulation: A solution in ethanol
Formal Name: 9α-hydroxy-11,15-dioxo-2,3,4,5-tetranor-prostanoic acid
Purity: ≥95%
Formula Markup: C16H26O5
Formula Weight: 298,4
Shelf life (days): 180
CAS Number: 1204116-69-7
Notes: A common metabolic pathway for several prostaglandins (PGs), including prostaglandin D2 (PGD2), involves the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs. The removal of four carbons at the α-terminus and oxidation of the terminal ω-carbon produces the abundant urinary metabolites, including tetranor-PGDM.{15162} 13,14-dihydro-15-keto-tetranor PGD2 is a potential metabolite of PGD2. It would be produced from the known metabolite 13,14-dihydro-15-keto PGD2 (Item No. 12610), which is a known agonist for the CRTH2/DP2 receptor.{5248}
English
Deutsch
